Jennifer Leary

3.4k total citations
18 papers, 629 citations indexed

About

Jennifer Leary is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Jennifer Leary has authored 18 papers receiving a total of 629 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 7 papers in Oncology and 6 papers in Genetics. Recurrent topics in Jennifer Leary's work include BRCA gene mutations in cancer (4 papers), Molecular Biology Techniques and Applications (3 papers) and Ovarian cancer diagnosis and treatment (3 papers). Jennifer Leary is often cited by papers focused on BRCA gene mutations in cancer (4 papers), Molecular Biology Techniques and Applications (3 papers) and Ovarian cancer diagnosis and treatment (3 papers). Jennifer Leary collaborates with scholars based in Australia, United Kingdom and United States. Jennifer Leary's co-authors include David W. Hedley, Martin H.N. Tattersall, Anna DeFazio, Michael Friedländer, Georgia Chenevix‐Trench, C.R.S. Houghton, Fred Kirsten, Patricia A. Mote, Christine L. Clarke and Richard Kefford and has published in prestigious journals such as PLoS ONE, International Journal of Cancer and Cancer Letters.

In The Last Decade

Jennifer Leary

18 papers receiving 604 citations

Peers

Countries citing papers authored by Jennifer Leary

Since Specialization

Citations

This map shows the geographic impact of Jennifer Leary's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jennifer Leary with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jennifer Leary more than expected).

Fields of papers citing papers by Jennifer Leary

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jennifer Leary. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jennifer Leary. The network helps show where Jennifer Leary may publish in the future.

Co-authorship network of co-authors of Jennifer Leary

This figure shows the co-authorship network connecting the top 25 collaborators of Jennifer Leary. A scholar is included among the top collaborators of Jennifer Leary based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jennifer Leary. Jennifer Leary is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work	Indexed citations
1	Multifactorial Likelihood Assessment of BRCA1 and BRCA2 Missense Variants Confirms That BRCA1:c.122A>G(p.His41Arg) Is a Pathogenic Mutation 2014 ·PLoS ONE ·Phillip J Whiley, Michael T. Parsons, Jennifer Leary, Kathy Tucker, Linda Warwick, (unknown), Heather Thorne, Sunil R. Lakhani, David E. Goldgar, Melissa A. Brown, Amanda B. Spurdle	20
2	Germ‐line mutations in BRCA1 or BRCA2 in the normal breast are associated with altered expression of estrogen‐responsive proteins and the predominance of progesterone receptor A 2004 ·Genes Chromosomes and Cancer ·Patricia A. Mote, Jennifer Leary, (unknown), Kerstin Sandelin, Georgia Chenevix‐Trench, Judy Kirk, Christine L. Clarke	66
3	Frequency of the ATM IVS10-6T→G variant in Australian multiple-case breast cancer families 2004 ·Breast Cancer Research ·Geoffrey J. Lindeman, (unknown), Jane E. Visvader, Jennifer Leary, Michael Field, Clara Gaff, (unknown), Kevin J. Trainor, (unknown), Graeme Suthers, Judy Kirk	15
4	Average age-specific cumulative risk of breast cancer according to type and site of germline mutations in BRCA1 and BRCA2 estimated from multiple-case breast cancer families attending Australian family cancer clinics 2003 ·Human Genetics ·Clare L. Scott, Mark A. Jenkins, Melissa C. Southey, (unknown), Jennifer Leary, Douglas F. Easton, Kelly‐Anne Phillips, John L. Hopper	31
5	High frequency of allelic imbalance at regions of chromosome arm 8p in ovarian carcinoma 2001 ·Cancer Genetics and Cytogenetics ·Ingrid Pribill, P Speiser, Jennifer Leary, Sepp Leodolter, Neville F. Hacker, Michael Friedländer, Daniel Birnbaum, Robert Zeillinger, Michael Krainer	31
6	Immunohistochemical Detection of Progesterone Receptors in Archival Breast Cancer 1998 ·Biotechnic & Histochemistry ·Patricia A. Mote, Jennifer Leary, Christine L. Clarke	16
7	Analysis of loss of heterozygosity andKRAS2 mutations in ovarian neoplasms: Clinicopathological correlations 1997 ·Genes Chromosomes and Cancer ·Georgia Chenevix‐Trench, (unknown), Terry Hurst, (unknown), David Purdie, Lee Bergman, Michael Friedländer, Barbara J.S. Sanderson, (unknown), (unknown), Jennifer Leary, Eric Crawford, Andrew N. Shelling, Inez Cooke, Trivadi S. Ganesan, J. Searle, Chan Choi, J. Carl Barrett, (unknown), Bruce G. Ward	44
8	MDR1 and multidrug resistance-associated protein (MRP) gene expression in epithelial ovarian tumors 1996 ·Cancer Letters ·Maria Kavallaris, Jennifer Leary, (unknown), Michael Friedländer	35
9	Allelic loss on chromosome 7q in ovarian adenocarcinomas: two critical regions and a rearrangement of the PLANH1 locus. 1996 ·PubMed ·J. F. R. Kerr, Jennifer Leary, (unknown), (unknown), Toni Antalis, M. Friedländer, (unknown), S. K. Khoo, Benjamin D. Ward, Georgia Chenevix‐Trench	34
10	Increased expression of the nme1 gene is associated with metastasis in epithelial ovarian cancer 1995 ·International Journal of Cancer ·Jennifer Leary, (unknown), Georgia Chenevix‐Trench, (unknown), Terry Hurst, C.R.S. Houghton, (unknown)	23
11	Investigation of loss of heterozygosity at specific loci on chromosomes 3p, 6q, lip, 17p and 17q in ovarian cancer 1993 ·International Journal of Gynecological Cancer ·Jennifer Leary, (unknown), (unknown), C.R.S. Houghton, Richard Kefford, Michael Friedländer	13
12	Amplification of HER-2/neu oncogene in human ovarian cancer 1992 ·International Journal of Gynecological Cancer ·Jennifer Leary, (unknown), C.R.S. Houghton, Richard Kefford, Michael Friedländer	17
13	In-situ hybridization using biotinylated DNA probes to human papillomavirus in adenocarcinoma-in-situ and endocervical glandular dysplasia of the uterine cervix 1991 ·Pathology ·Jennifer Leary, Richard Jaworski, R. Houghton	17
14	Amplification of c‐ras‐ki oncogene in human ovarian tumours 1989 ·International Journal of Cancer ·(unknown), Richard Kefford, Jennifer Leary, C.R.S. Houghton, Michael Friedländer	40
15	An evaluation of CA125, CA1 and peanut lectin immunoreactivity in epithelial ovarian neoplasms: correlation with histopathological features, prognostic variables and patient outcome 1988 ·Pathology ·Michael Friedländer, Jennifer Leary, Peter Russell	10
16	Immunohistochemical detection of proliferating cells in vivo. 1987 ·Journal of Histochemistry & Cytochemistry ·Anna DeFazio, Jennifer Leary, David W. Hedley, Martin H.N. Tattersall	152
17	Metastatic Adeno or Undifferentiated Carcinoma from an Unknown Primary Site Natural History and Guidelines for Identification of Treatable Subsets 1987 ·QJM ·Fred Kirsten, Heng Cao, Jennifer Leary, Alan B. P. Ng, David W. Hedley, Martin H.N. Tattersall	33
18	Metastatic adenocarcinoma of unknown primary site: Abnormalities of cellular DNA content and survival 1985 ·European Journal of Cancer and Clinical Oncology ·David W. Hedley, Jennifer Leary, Fred Kirsten	32

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact